Food and Drug Administration
PATS 461:1991 Paints and Varnishes — Reflectorized Traffic Paint (White and Yellow Premixed) — Specification PNS PNS 48:1994 PNS 10:2002 Specification PINS 2044:2005 Specifications Flor Wax — Water Emulsion — Specification Scouring Powder — Specifications Surface Active Agents — Laundry Soap Adhesives for Wall and Ceiling Boards —
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
Administrative Order
www.fda.gov.phsystems by developing innovative regulatory mechanisms for equitable distribution of quality and affordable health goods and services, FDA is currently undertaking efforts to streamline its processes and requirements and to automate and reengineer its systems. In the interest of public health and welfare protection, this Administrative Order is
ASEAN GUIDELINE ON STABILITY STUDY OF DRUG …
www.fda.gov.phINTRODUCTION 1 2. OBJECTIVES 1 3. SCOPES 1 4. DESIGN 1 4.1. General 1 4.2. ... Drug Products Intended for Storage in a Freezer 11 ... for a dose delivery system). The analytical procedure should be fully validated and stability indicating according to ASEAN guideline on Analytical Validation. Whether and
Guidelines, Introduction, Study, Drug, Stability, Delivery, Asean, Asean guideline on stability study of drug
Be it enacted by the Senate and House of Representatives ...
www.fda.gov.phBe it enacted by the Senate and House of Representatives of the Philippines in Congress assembled: SECTION 1 . Title – This Act shall be known as the "Special Law on Counterfeit Drugs." SECTION 2 . Declaration of Policy - It is hereby the policy of the State to protect and
Food and Drug Administration
www.fda.gov.phwhey & whey protein concentrate) (intended for children more than 36 months of a e and adults Sweetened Condensed Milk Liquid Milk (evaporated or ready to TEST/MICROORGANISM Reference Criteria Salmonella/25g, normal routine for high risk population SPC/APC, cfu/g Enterobacteriaceae cfu/g Coliforms, cfu/g Yeast and Molds Count, cfu/g SPC/APC, cfu/
Guidelines for Manufacturers and Traders
www.fda.gov.phThe exact statement, Keep out of the reach of children. _ 4. Electronic cigarette liquid solution volume in mL, rounded to the nearest 0.1mL. (e.g. 10.0 mL) 5. Nicotine concentration expressed in mg/mL nicotine or the words nicotine-free, as applicable, rounded to the nearest one mg/mL. 6. Batch/Lot number(s) 7. Expiry date 8.
Food and Drug Administration
www.fda.gov.phissuances provide list of medical devices that are required to be registered prior to sale, distribution and use. On 21 November 2Õ14, the Philippines, represented by the Secretary of ... validity of issued Certificate of Exemption (COE), and application fees for identified marketing authorizations. ... External b. Internal WER LOCK C/D C/D ...
CHECKLIST OF REQUIREMENTS FOR INITIAL ISSUANCE / …
www.fda.gov.pha license to operate (lto) a medical x-ray facility 1. duly accomplished medical x-ray license application form (2 copies). ... (for renewal application with no changes on current radiologist/s, this requirement is optional) 6. ... (for renewal application with no changes on current radiologic/ x-ray technologist/s, this requirement is optional) 7.
Food and Drug Administration
www.fda.gov.phRules and Regulations of R.A. No. 971 1, FDA has the power to mandate, order, review, and implement a Risk Management Plan (RMP) on any health product for conformance with FDA standards. Also, Book I, Article Il, A, Section 2 (l) requires all concerned to implement RMPs which is a requirement for the issuance of appropriate authorization.
Good distribution practices for pharmaceutical products
www.fda.gov.phThe material employed in the packaging of a pharmaceutical product. Containers include primary, secondary and transportation containers. Containers are referred to as primary if they are intended to be in direct contact with the product. Secondary containers are not intended to be in direct contact with the product. contamination
ASEAN Variation Guidelines For Pharmaceutical Products
www.fda.gov.phASEAN Variation Guideline for Pharmaceutical Products (R1) i LIST OF CONTENTS Page 1 INTRODUCTION 1 ... and/or directly the aspects of quality, safety and efficacy and it does not fall within the ... iii. SUPAC-MR: Modified Release Solid, Oral Dosage Forms, Scale-Up and Post-ASEAN Variation Guideline for Pharmaceutical Products (R1)
Guidelines, Product, Quality, Release, Modified, Oral, Modified release